Efficacy of a two-hour infusion of 150-mg tissue plasminogen activator in acute myocardial infarction

This publication has 29 references indexed in Scilit:

• Thrombolysis in Myocardial Infarction (TIMI) Trial, Phase I: A comparison between intravenous tissue plasminogen activator and intravenous streptokinase. Clinical findings through hospital discharge.
  Circulation, 1987
• Comparative properties of two clinical preparations of recombinant human tissue-type plasminogen activator in patients with acute myocardial infarction
  Journal of the American College of Cardiology, 1987
• A randomized, placebo-controlled trial of intravenous recombinant tissue-type plasminogen activator and emergency coronary angioplasty in patients with acute myocardial infarction.
  Circulation, 1987
• Dose-dependent thrombolysis, pharmacokinetics and hemostatic effects of recombinant human tissue-type plasminogen activator for coronary thrombosis
  The American Journal of Cardiology, 1986
• Noninvasive detection of coronary artery patency using continuous ST-segment monitoring
  The American Journal of Cardiology, 1986
• Accelerated Thrombolysis In Vitro Evaluation of Agents and Methods of Administration
  Investigative Radiology, 1985
• RANDOMISED TRIAL OF INTRAVENOUS RECOMBINANT TISSUE-TYPE PLASMINOGEN ACTIVATOR VERSUS INTRAVENOUS STREPTOKINASE IN ACUTE MYOCARDIAL INFARCTION
  The Lancet, 1985
• Coronary thrombolysis with recombinant human tissue-type plasminogen activator: a prospective, randomized, placebo-controlled trial.
  Circulation, 1984
• The sulphite precipitation method for fibrinogen measurement; Its use on small samples in the presence of fibrinogen degradation products
  Clinica Chimica Acta; International Journal of Clinical Chemistry, 1976
• Gerinnungsphysiologische Schnellmethode zur Bestimmung des Fibrinogens
  Acta Haematologica, 1957